B. Braun informed: Reporting requirement according to paragraph 33 of the ‘REACH’ regulation (EG No. 1907/2006)
B. Braun confirms with the CE-labelling and with the declaration of conformity of our medical devices that the respective products are in compliance with the “essential requirements” of the European Medical Device Directive (93/42/EWG) dated June 14th, 1993 and the German Act on Medical Devices.
This includes that the below mentioned medical devices are designed and manufactured in a way that when used under the conditions and for the purpose intended, they will not compromise the clinical condition or the safety of patients nor the safety and health of users or third parties if the products are used under the intended condition and purpose. Respective assessments are executed e.g. in combination with the implementation of the risk management system according to ISO 14971.
Since adoption of the European Directive ‚REACH’ (Registration, Evaluation and Authorisation of Chemicals) we have to inform which devices include a substance named in the so called list of candidates in a concentration of more than 0.1 mass percentage. This list has been announced to public on the ‘ECHA’ website (European chemical Agency) on October 28th, 2008 and has been updated continuously.
According to substances published in the list of candidates DEHP (Bis (2-ethyl (hexyl) phthalate), DOTE (2-ethylhexyl 10-ethyl-4,4-dioctyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate) and PZT (Lead titanium zirconium oxide) are present in relevant concentrations in some of our products / medical devices.
The affected products from the divisions Hospital Care and OPM, the DEHP (CAS Number: 117-81-7) to more than 0.1 mass percentage mentioned are labeled as follows:
The identification is based on the following rules: Directives 67/548/EEC, 1999/45/EC and EC Regulation No. 1272/2008 (CLP Regulation) and the REACH Regulation (1907/2006).
Products containing DOTE (CAS Number: 15571-58-1) with more than 0.1 mass percentage are listed in the attached letter.
Furthermore, the air sensor installed in the Infusomat Space and Infusomat Compact Plus contains the substance PZT (CAS No. 12626-81-2) in relevant concentration.
With attached information we comply with the obligation to provide information in compliance with article 33 § 1 of the REACH Regulation.
Document about "REACH" for Hospital Care Division and Out Patient Market Division
|pdf (7.0 MB)||open|
Reporting requirement according to paragraph 33 of the REACH regulation B. Braun Avitum AG
|pdf (123.1 KB)||open|
Reporting requirement according to paragraph 33 of the REACH regulation B. Braun Avitum Italy S.p.A.
|pdf (1.7 MB)||open|